4//SEC Filing
King Adam 4
Accession 0001493152-23-022833
CIK 0001310527other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 6:14 AM ET
Size
9.1 KB
Accession
0001493152-23-022833
Insider Transaction Report
Form 4
King Adam
Chief Financial Officer
Transactions
- Award
Common Stock
2023-06-23+20,910→ 20,910 total - Award
Common Stock
2023-06-23+2,040→ 22,950 total - Award
Options to buy common stock
2022-03-03+12,500→ 12,500 totalExercise: $10.00Exp: 2032-03-03→ Common Stock (12,500 underlying)
Footnotes (3)
- [F1]This award of shares is being made pursuant to the Issuer's restricted stock award agreement and is subject to a vesting schedule, such that a portion or all of this award of restricted stock may be forfeited in the future if certain milestones are not met.
- [F2]Shares acquired upon conversion of deferred salary of $10,200.
- [F3]As of 3/31/2023, 9,375 shares vested based on performance. The balance of the shares will vest in 36 monthly installments commencing March 1, 2023.
Documents
Issuer
QSAM Biosciences, Inc.
CIK 0001310527
Entity typeother
Related Parties
1- filerCIK 0001983355
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 6:14 AM ET
- Size
- 9.1 KB